Table 1.
Demographic and laboratory data of the patients with NAFLD.
| Variable | Total (n = 48) | BMP < 745.50 pg/ml (n = 24) | BMP ≥ 745.50 pg/ml (n = 24) | P value |
|---|---|---|---|---|
| Age, years old | 42. 67 ± 12.59 | 41.56 ± 11.66 | 43.22 ± 13.32 | 0.989 |
| Gender, male/female | 23/25 | 13/11 | 10/14 | 0.657 |
| Weight, kg | 102.77 ± 12.97 | 103.44 ± 12.21 | 102.10 ± 13.92 | 0.725 |
| BMI, kg/m2 | 35.99 ± 4.27 | 36.33 ± 4.06 | 35.66 ± 4.52 | 0.592 |
| TCH, mmol/l | 5.36 ± 0.97 | 5.53 ± 0.95 | 5.21 ± 0.98 | 0.272 |
| TG, mmol/l | 1.66 (1.55,2.73) | 1.66 (1.52,2.28) | 1.65 (1.52,2.61) | 0.523 |
| LDL-C, mmol/l | 3.23 ± 0.89 | 3.23 ± 0.99 | 3.23 ± 0.81 | 0.981 |
| FFA, mmol/l | 0.59 ± 0.17 | 0.59 ± 0.15 | 0.59 ± 0.19 | 0.994 |
| SOD, U/ml | 146.95 ± 23.00 | 139.32 ± 21.26 | 153.86 ± 22.79 | 0.044 |
| ALT, U/L | 38.20 (22.50,45.92) | 38.60 (24.37,42.37) | 34.95 (22.42,54.02) | 0.930 |
| AST, U/L | 24.05 (17.30,32.65) | 24.40 (17.90,30.15) | 23.00 (17.10,45.40) | 0.597 |
| FBG, mmol/l | 8.29 ± 3.68 | 7.95 ± 3.62 | 8.61 ± 3.78 | 0.560 |
| INS, mU/L | 28.10 ± 13.73 | 32.54 ± 13.27 | 23.47 ± 12.91 | 0.025 |
NAFLD nonalcoholic fatty liver disease, BMI body mass index, TCH total cholesterol, TG triglyceride, LDL-C low-density lipoprotein cholesterol, FFA free fatty acid, SOD superoxide dismutase, ALT alanine transaminase, AST aspartate aminotransferase, FBG fasting blood glucose, FINS fasting insulin.